Carbohydrate ligand engagement with CD11b enhances differentiation of tumor-associated myeloid cells for immunotherapy of solid cancers

BACKGROUND: Efforts to modulate the function of tumor-associated myeloid cell are underway to overcome the challenges in immunotherapy and find a cure. One potential therapeutic target is integrin CD11b, which can be used to modulate the myeloid-derived cells and induce tumor-reactive T-cell respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Roche, Veronique, Sandoval, Victor, Wolford, Claire, Senders, Zachary, Kim, Julian Anthony, Ribeiro, Susan Pereira, Huang, Alex Yicheng, Sekaly, Rafick-Pierre, Lyons, Joshua, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314662/
https://www.ncbi.nlm.nih.gov/pubmed/37399354
http://dx.doi.org/10.1136/jitc-2022-006205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314662/
https://www.ncbi.nlm.nih.gov/pubmed/37399354
http://dx.doi.org/10.1136/jitc-2022-006205

Ejemplares similares